Vital is a podcast by Polígrafo and Viral, in partnership with the Champalimaud Foundation.

This episode was hosted by journalist Marta Sofia Ribeiro.

The Champalimaud Foundation is in no way responsible for the data, information or viewpoints expressed within the context of the project, nor is it bound by them. Responsibility for these, under applicable law, lies solely with the authors, the interviewees, the editors or the distributors of the initiative.

Vital is a podcast by Polígrafo and Viral, in partnership with the Champalimaud Foundation.

This episode was hosted by journalist Marta Sofia Ribeiro.

The Champalimaud Foundation is in no way responsible for the data, information or viewpoints expressed within the context of the project, nor is it bound by them. Responsibility for these, under applicable law, lies solely with the authors, the interviewees, the editors or the distributors of the initiative.

Vital is a podcast by Polígrafo and Viral, in partnership with the Champalimaud Foundation.

This episode was hosted by journalist Sara Beatriz Monteiro.

The Champalimaud Foundation is in no way responsible for the data, information or viewpoints expressed within the context of the project, nor is it bound by them. Responsibility for these, under applicable law, lies solely with the authors, the interviewees, the editors or the distributors of the initiative.

Vital is a podcast by Polígrafo and Viral, in partnership with the Champalimaud Foundation.

This episode was hosted by journalist Marta Sofia Ribeiro.

The Champalimaud Foundation is in no way responsible for the data, information or viewpoints expressed within the context of the project, nor is it bound by them. Responsibility for these, under applicable law, lies solely with the authors, the interviewees, the editors or the distributors of the initiative.

Vital is a podcast by Polígrafo and Viral, in partnership with the Champalimaud Foundation.

This episode was hosted by journalist Marta Sofia Ribeiro.

The Champalimaud Foundation is in no way responsible for the data, information or viewpoints expressed within the context of the project, nor is it bound by them. Responsibility for these, under applicable law, lies solely with the authors, the interviewees, the editors or the distributors of the initiative.

Vital is a podcast by Polígrafo and Viral, in partnership with the Champalimaud Foundation.

This episode was hosted by journalist Marta Sofia Ribeiro.

The Champalimaud Foundation is in no way responsible for the data, information or viewpoints expressed within the context of the project, nor is it bound by them. Responsibility for these, under applicable law, lies solely with the authors, the interviewees, the editors or the distributors of the initiative.

Vital is a podcast by Polígrafo and Viral, in partnership with the Champalimaud Foundation.

This episode was hosted by journalist Sara Beatriz Monteiro.

The Champalimaud Foundation is in no way responsible for the data, information or viewpoints expressed within the context of the project, nor is it bound by them. Responsibility for these, under applicable law, lies solely with the authors, the interviewees, the editors or the distributors of the initiative.
 

The initiative aims to strengthen health literacy through accessible, educational content based on the best available scientific evidence.

Developed through a partnership between the Champalimaud Foundation and the Faculdade de Medicina da Universidade de Lisboa (FMUL), the programme supports the career development of surgeons and clinician-scientists committed to advancing cancer research. The PhD degree is granted by FMUL within the framework of the Lisbon Academic Medical Centre PhD Programme.

A study just published in the prestigious Journal of Clinical Oncology definitively establishes the introduction of low-dose Tamoxifen into clinical practice as post-surgical therapy for the prevention of ductal carcinoma in situ (DCIS), the initial non-invasive form that accounts for around 25% of all breast cancers diagnosed through mammographic screening.